Cargando…
Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis
Delpazolid, an oxazolidinone, has been studied in non-clinical studies of efficacy and toxicity and Phase 1 clinical studies. Delpazolid has in vitro activity against Gram-positive bacteria, including Mycobacterium tuberculosis. This study evaluated the bactericidal activity, safety, and pharmacokin...
Autores principales: | Kim, Ju Sang, Kim, Yong-hyun, Lee, Sang Haak, Kim, Yee Hyung, Kim, Jin-woo, Kang, Ji Young, Kim, Sung Kyoung, Kim, Seung Joon, Kang, Yun-Seong, Kim, Tae-hyung, Mok, Jeongha, Byun, Min Kwang, Park, Hye Jung, Joh, Joon-sung, Park, Yong Bum, Lim, Hyeong-Seok, Choi, Hongjo, Lee, Seung Heon, Kim, Hyejin, Yang, Jeongseong, Kim, Hyunji, Shen, Xianlin, Alsultan, Abdullah, Cho, InSook, Geiter, Lawrence, Shim, Tae Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846473/ https://www.ncbi.nlm.nih.gov/pubmed/34871098 http://dx.doi.org/10.1128/aac.01684-21 |
Ejemplares similares
-
Effect of food on the pharmacokinetic characteristics of a single oral dose of LCB01-0371, a novel oxazolidinone antibiotic
por: Sunwoo, Jung, et al.
Publicado: (2018) -
In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus
por: Oh, Sang-Hun, et al.
Publicado: (2017) -
In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria
por: Oh, Sang-Hun, et al.
Publicado: (2017) -
Antibacterial Activity of LCB10-0200 against Klebsiella pneumoniae
por: Oh, Sang-Hun, et al.
Publicado: (2021) -
In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection
por: Park, Jeong Su, et al.
Publicado: (2023)